Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for the treatment of apathy in Alzheimer's dementia
DRKS00000103Phase 3Completed
- Sponsor
- University of Bonn
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) and apathy comparing Bupropion with Placebo (2 arms). Started Jan 2010; status: completed.
02
Drugs
bupropion
03
Conditions
Alzheimer's disease (AD)apathy
Beyond the preview
Go deeper on DRKS00000103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000103.